biostudies-literatureUnknown19(1)Kawamura Y<h4>Objective</h4>Endovascular treatment of wide-neck cerebral aneurysms with conventional coiling alone remains challenging. Stent-assisted coiling using a vascular reconstruction device offers an alternative strategy. This study evaluated the safety and effectiveness of the Enterprise Vascular Reconstruction Device (Cerenovus, Irvine, CA, USA) in patients with wide-neck cerebral aneurysms.<h4>Methods</h4>Post-marketing surveillance records were collected for all Enterprise stent usage using case report forms at 30 days and at 1, 2, and 3 years post-procedure. A total of 738 cases, including 411 on-label cases, were analyzed across 83 hospitals.<h4>Results</h4>Stent deployment was successful in 98.8% of cases, and the overall procedure success rate was 93.9% immediately post-procedure. ThJournal of neuroendovascular therapy2025-0063https://www.ebi.ac.uk/biostudies/studies/S-EPMC12530950biostudies-literatureVascular Reconstruction Device for Coil Embolization of Wide-Neck Type Cerebral Aneurysm: Findings from a Post-Marketing Surveillance Study in Japan.PMC12530950Kawamura YHonda ATaki WSakai CIto YKuwayama NImamura HHyodo AIzumi TMatsumaru YMiyachi SSakai NfalseVascular Reconstruction Device for Coil Embolization of Wide-Neck Type Cerebral Aneurysm: Findings from a Post-Marketing Surveillance Study in Japan.<h4>Objective</h4>Endovascular treatment of wide-neck cerebral aneurysms with conventional coiling alone remains challenging. Stent-assisted coiling using a vascular reconstruction device offers an alternative strategy. This study evaluated the safety and effectiveness of the Enterprise Vascular Reconstruction Device (Cerenovus, Irvine, CA, USA) in patients with wide-neck cerebral aneurysms.<h4>Methods</h4>Post-marketing surveillance records were collected for all Enterprise stent usage using case report forms at 30 days and at 1, 2, and 3 years post-procedure. A total of 738 cases, including 411 on-label cases, were analyzed across 83 hospitals.<h4>Results</h4>Stent deployment was successful in 98.8% of cases, and the overall procedure success rate was 93.9% immediately post-procedure. Th2025-01-01T00:00:00Z20252026-06-04T14:29:32.201Z2026-05-10T03:11:26.024ZS-EPMC125309504111296610.5797/jnet.oa.2025-0063